CVS Health Corp. closed $34.74 short of its 52-week high ($80.75), which the company reached on March 28th.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $65.0 for CVS Health over the last 3 months.

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...

In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on CVS Health (CVS – Research Report), with a price target of ...

Multiple reports indicate that employers can expect rising healthcare costs in 2025. To address these costs, employers are ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.BYxs733P.js ...

Shares of CVS Health Corp. CVS slid 0.09% to $45.78 Tuesday, on what proved to be an all-around poor trading session for the ...

CVS Health has announced that all commercial prescriptions dispensed through its pharmacies will be now contracted through the company's CostVantage reimbursement model. The model ...

The community was given a bit of a shock recently when CVS announced that it would be leaving its downtown Cumberland location on Jan. 30.

The Consumer Financial Protection Bureau has estimated that this could boost the credit scores of people with medical debt by an average of 20 points, potentially improving their access to housing and ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...